Cancer and Oncology Terms

A substance that is being studied in the treatment of cancer.

A substance that is being studied in the treatment of cancer.

A drug used to treat metastatic or locally advanced breast cancer that has not improved after treatment with certain other anticancer drugs.

A substance that is being studied in the treatment of cancer.

A drug used to treat certain types of chronic myeloid leukemia and acute lymphoblastic leukemia.

A substance that is being studied in the treatment of cancer.

An abbreviation from older drug references for jaw bone that dies and stays exposed during treatment with bone strengthening medicines.

Bone cancer includes primary tumors that arise directly within bone tissue and secondary tumors that spread there from cancer elsewhere in the body.

This umbrella term spans several distinct diseases with different outlooks, so identifying the specific type is essential to understanding what it means.

Cancer that has spread from the original (primary) tumor to the bone marrow.

Cancer that has settled in bone, where it keeps the name of the organ it started in rather than the bone it now occupies.

A radioactive substance that is given through a vein, and collects in bone cells and in tumor cells that have spread to the bone.

A benign (not cancer) condition in which an overgrowth of prostate tissue pushes against the urethra and the bladder, blocking the flow of urine.

A substance being studied in the treatment of cancer.

Brachytherapy delivers radiation from a sealed source placed directly inside or next to a tumor, concentrating the dose while sparing nearby tissue.

Cancer in the brain has far more often arrived from elsewhere than started there, and that origin decides how it is treated.

A tumor located in the part of the brain that connects to the spinal cord (the brain stem).

A tumor in the part of the brain that connects to the spinal cord (the brain stem).

Inside a closed skull, even a growth that never spreads anywhere can do harm simply by taking up room.

Receptor testing turned one disease into several, since what a tumor responds to now shapes treatment more than its size does.